Dr. Grosberg explains the phenomena of status migrainosus and challenges with treatment.
Unrecognized Challenges of Treating Status Migrainosus: An Observational Study
Dr Grosberg discloses the following:
-Consulting fees or paid advisory boards with Theranica, with Amgen, Alder, Lundbeck, Biohaven, Allergan, and Neurolief between 2018-2020.
-Equity ownership or stock options from Theranica in 2019.
-Lecture fees or honoraria from speaking at the invitation of a commercial sponsor from Amgen, Alder, Lundbeck, Theranica, Biohaven, Allergan (for the past two years or known future).